|

P2Y12 inhibitor Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Insel Gruppe AG, University Hospital Bern1

Indications

  • P2Y12 Inhibitor1
  • Oral Anticoagulation1
  • Percutaneous Coronary Intervention (PCI)1
  • Atrial Fibrillation (AF)1
  • Heart Disease1

Other1 trial

Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.